United States · FDA National Drug Code directory
DAXXIFY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72960-112_71c76e28-0eb6-487e-a53b-4c9e78021e57
- Product NDC
- 72960-112
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- botulinum toxin type A
- Labeler
- Revance Therapeutics, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20220920
- Source listing expiry
- 20271231
Source-listed ingredients
- BOTULINUM TOXIN TYPE A — 100 U/1.2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-01) / 1.2 mL in 1 VIAL, SINGLE-USE · 72960-112-01
- 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-02) / 1.2 mL in 1 VIAL, SINGLE-USE · 72960-112-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →